Anaphylaxis Checklist for Pharmacists

pdfAnaphylaxis Checklist for Pharmacists202.75 KBAnaphylaxis Checklist for Pharmacists 

1. Provide advice

  • Provide advice about medications for treating allergic reactions. Advise patients that adrenaline (epinephrine) is the first line treatment for anaphylaxis and that antihistamines should not be used as initial treatment for anaphylaxis even when requested by patients. If using antihistamines for mild to moderate allergic reactions, non-sedating antihistamines should be used.
  • Advise patients with unconfirmed allergic reactions to see their medical practitioner.

2. Dispense adrenaline autoinjectors and teach patients/carers how to use them

  • Only dispense the specific adrenaline (epinephrine) autoinjector prescribed (e.g. EpiPen®).
  • Appropriate dose for weight: 10-20kg - 0.15mg device; Over 20kg - 0.30mg device.
  • Teach the patient and carer how to use their prescribed adrenaline autoinjector using a matching trainer device and provide Consumer Medicine Information. Training must be brand specific.
  • Remind patients and carers to check the expiry date of their autoinjector.
  • Inform patients and carers of expiry reminder clubs (e.g. EpiClub).

3. Provide adrenaline autoinjector education and confirm the patient has an ASCIA Action Plan for Anaphylaxis

  • Reinforce the need for the patient to ALWAYS carry their adrenaline autoinjector and their ASCIA Action Plan.
  • Educate about correct storage of adrenaline autoinjectors and how to protect the device from excessive heat or excessive cooling.
  • Check patients have the correct ASCIA Action Plan for the brand of adrenaline autoinjector dispensed.

4. Optimise asthma control

  • Check asthma is well managed and refer back to medical practitioner if further action is required. Patients at risk of anaphylaxis who have asthma that is not well controlled are at increased risk of fatal anaphylaxis.

5. Be prepared for an anaphylaxis emergency

  • Train staff to recognise the signs and symptoms of severe allergic reactions (anaphylaxis).
  • Train pharmacists on how to administer adrenaline autoinjectors and be prepared to administer in an anaphylaxis emergency.
  • Call an ambulance for assistance when treating a patient with acute anaphylaxis immediately after administration of an adrenaline autoinjector.
  • Display ASCIA Action Plans for Anaphylaxis to assist staff in recognising and responding to an anaphylaxis emergency.

Further information is available on the ASCIA website 

© ASCIA 2016

Content updated June 2016

Mod ASCIA Member
Donate to AIFA
go to NAS website
Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:


ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.



This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.